Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Cancer Therapies02:49

Cancer Therapies

8.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.3K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

15.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.3K
Regulation of Metabolism01:19

Regulation of Metabolism

10.4K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
10.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MicroRNA Expression Profile in Endometriosis and Endometriosis-Associated Ovarian Cancer-Systematic Review.

Cells·2026
Same author

Editorial Dr. Joseph A. Helpern.

NMR in biomedicine·2025
Same author

Neuroinflammation is responsible for pain in endometriosis - targeting the JAK-STAT pathway and mast cell activation.

Frontiers in immunology·2025
Same author

Glomangiopericytoma of the Infraorbital Region.

Head and neck pathology·2025
Same author

IgG4-related disease presenting as central skull base osteomyelitis with deep neck abscesses: A case report.

Medicine·2025
Same author

Complement and coagulation cascade cross-talk in endometriosis and the potential of Janus Kinase inhibitors-a network meta-analysis.

Frontiers in immunology·2025

Related Experiment Video

Updated: Oct 18, 2025

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions
09:17

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions

Published on: August 2, 2018

18.4K

HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells.

Shen-Han Lee1, Monika Golinska2,3, John R Griffiths2

  • 1Department of Otorhinolaryngology, Hospital Sultanah Bahiyah, KM6 Jalan Langgar, Alor Setar 05460, Kedah, Malaysia.

Cells
|September 28, 2021
PubMed
Summary

Hypoxic tumors adapt to HIF-1 inhibition through metabolic changes, potentially causing drug resistance. Further research into these hypoxia bypass mechanisms is crucial for effective cancer therapy.

Keywords:
2-hydroxyglutarateAMP-activated protein kinase (AMPK)Myccancer metabolismcreatine metabolismglutamine metabolismglycolysishypoxiahypoxia-inducible factor-1 (HIF-1)lipid metabolismphosphatidylinositol 3-kinase (PI3K)

More Related Videos

Induction and Testing of Hypoxia in Cell Culture
07:01

Induction and Testing of Hypoxia in Cell Culture

Published on: August 12, 2011

85.5K
Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
08:34

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis

Published on: June 3, 2016

15.4K

Related Experiment Videos

Last Updated: Oct 18, 2025

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions
09:17

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions

Published on: August 2, 2018

18.4K
Induction and Testing of Hypoxia in Cell Culture
07:01

Induction and Testing of Hypoxia in Cell Culture

Published on: August 12, 2011

85.5K
Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
08:34

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis

Published on: June 3, 2016

15.4K

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Metabolism

Background:

  • Solid tumors contain hypoxic microenvironments where cancer cells adapt metabolically.
  • Hypoxia-Inducible Factor 1 (HIF-1) drives this adaptation and is overexpressed in many cancers.
  • HIF-1 inhibitors are in clinical trials, but cancer cells may develop resistance.

Purpose of the Study:

  • To review evidence of metabolic adaptations allowing cancer cells to survive hypoxia despite HIF-1 inhibition.
  • To identify HIF-1-independent mechanisms that contribute to drug resistance against anti-HIF-1 therapy.
  • To highlight areas for future research in hypoxia bypass mechanisms.

Main Methods:

  • Literature review of accumulating evidence on cancer cell adaptation to hypoxia.
  • Analysis of metabolic pathways including carbohydrate, creatine, glucose, glutamine, and lipid metabolism.
  • Examination of HIF-1-independent mechanisms such as epigenetic modifications, protein alterations, and signaling pathways.

Main Results:

  • Hypoxic cancer cells exhibit metabolic adaptations in carbohydrate and creatine metabolism.
  • HIF-1-independent pathways, including glucose, glutamine, lipid metabolism, and signaling pathways (Myc, PI3K-Akt, AMPK), contribute to survival.
  • Activation of the HIF-2 pathway and epigenetic/post-translational modifications are also identified resistance mechanisms.

Conclusions:

  • Cancer cells can develop resistance to HIF-1 inhibition through various metabolic and signaling adaptations.
  • Targeting HIF-1β might be advantageous but carries risks of off-target effects due to its role as ARNT.
  • Future cancer therapies targeting hypoxia must carefully consider and address potential resistance mechanisms.